Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Experts created guidelines to better diagnose and treat uncommon fungal skin infections.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Medical associations need to create more resources to improve healthcare for incarcerated individuals.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.